Dual site antibody-base immunoassays are commonly used in clinical laborato
ries to quantify the CT serum concentrations as a specific and sensitive ma
rker of medullary thyroid carcinoma (MTC). Heterophile antibodies can inter
fere with these assays, however, and cause erroneous results. In order to a
void this interference, immobilized and conjugated antibodies from two diff
erent animal species or immunoreactive antibody fragments, as well as the a
ddition of non-immune globulins, are generally included among the assay rea
gents. We describe the case of a 73-year-old man affected by a multinodular
goiter, who showed high basal CT plasma levels as measured by a monoclonal
antibody based IRMA. The finding of negative results for the presence of M
TC at fine needle aspiration (FNA) and the mild increase observed in plasma
CT during a pentagastrin (Pg) stimulation test, suggested that the high CT
levels might depend on a cross-reaction with heterophilic antibodies. In f
act, after the addition of the heterophilic blocking tube (HBT) to each spe
cimen, the CT levels markedly decreased by more than 80% (average decrease
+/- SE= 87.6 +/-2.668%). Such a decrease strongly suggests that in our case
the routinely used F(ab ')(2) fragments were unable to eliminate all of th
e interference and that the elevated serum CT levels might have been caused
by human heterophilic antibodies. In conclusion, these results indicate a
novel cause of CT false positivity, suggesting that high serum CT levels, w
hen combined with a slight increase during Pg stimulation, should be critic
ally interpreted in view of the possible presence of heterophilic antibodie
s in the specimens.